Skip to main content
Iranian Journal of Public Health logoLink to Iranian Journal of Public Health
letter
. 2021 Sep;50(9):1926–1929. doi: 10.18502/ijph.v50i9.7081

Why Is COVID-19 More Concentrated in Countries with High Economic Status?

Mohsen Bayati 1,*
PMCID: PMC8542832  PMID: 34722396

Dear Editor-in-Chief

Having been detected first in December 2019 in Wuhan, China, COVID-19 has infected more than 209 million people and killed 4,393,512 ones worldwide until August 17, 2021 (1). The disease, which was called pandemic on March 11, 2020 (2), has had significant social and economic effects around the world. Ecological data show that the pandemic has had a significantly higher prevalence and death in more developed and higher income countries so far (3). In this regard, using data related to COVID-19 from World meter (1) and per capita income from World Bank data bases until November 29, 2020, I analyzed the issue. Distribution of COVID-19 death and prevalence between high income countries and others, and regression of the prevalence and deaths from COVID-19 on the countries’ per capita income are performed.

According to the statistical analysis by the author, the prevalence of COVID-19 in high income countries is three time higher than other countries (17371 vs. 6180 per 1 million population). There is also similar status for critical cases and death related COVID-19 (Table 1). Moreover, according to a simple regression estimates, the prevalence and deaths from COVID-19 are significantly related to countries’ per capita income (Fig. 1).

Table 1:

Comparison of some COVID-19 indicators between high income countries and others*

Comparison indicators High income countries *** Other countries
Prevalence** 17371.56 6180.01
Death** 289.68 147.33
Test** 401758.46 71841.31
Critical cases** 47.46 15.81
GDP per capita (USD) 43797.13 4186.27
*

Distribution of COVID-19 death and prevalence between high income countries and others are reported based on author’s statistical analysis.

**

Per 1 million population in November 29, 2020

***

Countries with a GNI per capita of $12,696 or more (according to the word bank: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups)

Fig. 1:

Fig. 1:

Regression line of COVID-19 prevalence and death rates (per 1 million population) on GDP per capita (current USD)*

In the regression model, which is analyzed by the author, data of COVID-19 mortality and morbidity, and GDP per capita were collected from Worldometer (1) and World Bank data bases, respectively. Moreover, axes are in logarithmic scale

It is so important to assert that the assumption of higher reported COVID-19 prevalence and death rates in higher income countries is according to the only author’s statistical analysis (until November 29, 2020) which is elaborated above. So current letter and the following debates are according to the author’s assumption.

To answer the question why more developed countries are facing a much higher prevalence and death rates than poor countries, the following possibilities are suggested:

  • -More developed countries usually have older populations (4), and as noted by researchers, age is a key risk factor for spreading and dying from COVID-19 (5). Thus, developed countries are more prone to the outbreak of the disease and its outcomes. According to the United Nations (2017), about 20–25% of the population in Europe and North America are over 60 year old, while the rate is about 5% in Africa and below 15% in other countries (4).

  • -Having underlying diseases such as diabetes, cardiovascular disease, and other chronic diseases was one the most important risk factors for the COVID-19 especially its severe state and the resulting death (5, 6). There are much more of these risk factors in high-income countries than in other ones. For example, according to the latest Global Burden of Disease statistics (2017), the prevalence (per 100,000 population) of cardiovascular diseases in the countries with high, upper middle, lower middle, and low income was 11075, 7284, 4438 and 3198, respectively. Similarly, the prevalence of diabetes in high, upper middle, lower middle, and low income countries was 9097, 6567, 5414 and 3578 (per 100,000 population), respectively (7).

  • -In high-income countries where there are more resources and better medical infrastructures (a larger number of more specialized human resources, and greater and more developed medical technology, especially laboratory equipment and diagnostic kits), a much larger number of COVID-19 diagnosis test are performed (1). Consequently, the number of detected cases and deaths is larger. Having weak infrastructures, some poor countries are not able to even address routine population health needs (8).

  • -There is much lower air transport and passengers in poor countries than in developed ones (9). Therefore, the transmission of the virus from the early places like China, East Asia, and then Europe and the United States, to the poor countries has been less likely.

  • -Countries with the highest prevalence of COVID-19 (mainly developed countries) are likely to disseminate the data more transparently and more accurately. Williams showed that information transparency had a positive relationship with countries’ income levels (10).

  • -Finally, other factors such as environmental situation, geographical conditions, socio-demographic factors, and even economic factors may play a role in the spread of the disease, which require to be carefully studied.

In general, it seems that the more risk factors of the disease (age, underlying diseases, etc.), diagnostic tests, air transport, and information transparency in high-income countries lead to the higher prevalence and deaths from COVID-19 compared to lower-income countries.

Footnotes

Conflict of interest

The authors declare that there is no conflict of interests.

References


Articles from Iranian Journal of Public Health are provided here courtesy of Tehran University of Medical Sciences

RESOURCES